May 31, 2024- September 18, 2023Yumanity Therapeutics, headquartered in Boston, was established in December 2014 as an independent biotechnology company focused on drug development targeting…
September 11, 2023The client is a small, clinical-stage oncology company focused on developing novel medicines for metastatic breast cancer patients.
August 21, 2022Establishment of a Long-Term Medical Writing Partnership In 2009, IMPACT (now part of Syner-G BioPharma Group) was contracted by a…- August 9, 2022In 2010, following a referral from another company, IMPACT (now part of Syner-G BioPharma Group) was contacted by a mid-size…
- August 9, 2022In 2011, following referral from another company, IMPACT (now part of Syner-G BioPharma Group) was contacted by a small development…
- August 9, 2022IMPACT (now part of Syner-G BioPharma Group) has been providing Regulatory Affairs support to a mid-size pharmaceutical company since 2009. …
- August 9, 2022In 2013, the IMPACT (now part of Syner-G BioPharma Group) management team decided that the company needed to build a…
- August 9, 2022As a result of repeat business, IMPACT (now part of Syner-G BioPharma Group) was contracted by a large, global pharmaceutical…
